Related Experiment Video

Updated: Aug 8, 2026

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing
08:34

RNA Interference-based Investigation of the Function of Heat Shock Protein 27 during Corneal Epithelial Wound Healing

Published on: September 27, 2016

[Effects of RNA interference on epidermal growth factor receptor expression in SPC-A-1 cells]

Min Zhang1, Xin Zhang, Chun-xue Bai

  • 1Institute of Respiratory Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Zhonghua Nei Ke Za Zhi
|June 9, 2004
PubMed
Abstract

Insights

Small interference RNA (siRNA) effectively suppressed epidermal growth factor receptor (EGFR) in non-small-cell lung cancer (NSCLC) cells. This RNA interference therapy inhibited proliferation, induced cell cycle arrest, and enhanced cisplatin sensitivity.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • RNA Therapeutics

Background:

  • Epidermal growth factor receptor (EGFR) is a key driver in non-small-cell lung carcinoma (NSCLC) progression.
  • Targeting EGFR is a validated strategy for NSCLC treatment.
  • RNA interference (RNAi) offers a novel approach to gene silencing.

Purpose of the Study:

  • To evaluate the efficacy of small interference RNA (siRNA) in suppressing EGFR expression in NSCLC cells.
  • To assess the impact of EGFR suppression on NSCLC cell proliferation and cell cycle.
  • To determine the combined effect of EGFR inhibition and cisplatin on NSCLC chemosensitivity.

Main Methods:

  • Transfection of SPC-A-1 NSCLC cells with chemically synthesized double-stranded RNA (dsRNA) targeting EGFR using Lipofectamine 2000.
  • Quantification of EGFR expression via Western blot and flow cytometry.
  • Assessment of anti-proliferative effects using cell counts and colony assays; cell cycle analysis by flow cytometry; chemosensitivity evaluation using MTT assay.

Main Results:

  • Sequence-specific siRNAs targeting EGFR significantly downregulated EGFR expression.
  • dsRNA-EGFR reduced cell numbers by 78.3% and colonies by 66.8%.
  • dsRNA-EGFR induced G0-G1 phase cell cycle arrest and increased sensitivity to cisplatin seven-fold.

Conclusions:

  • siRNA-mediated EGFR suppression effectively inhibits NSCLC proliferation and induces cell cycle arrest.
  • EGFR-targeted dsRNA demonstrates synergistic effects with cisplatin for enhanced tumor growth inhibition.
  • This study validates dsRNA-EGFR as a promising therapeutic strategy for EGFR-overexpressing NSCLC.

More Related Videos

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration08:55

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...